reven.comHealthcareFounded: 1999Funding to Date: $106.23MM
Reven Pharmaceuticals is a biopharmaceutical company developing solutions for those suffering the effects of vascular and metabolic related diseases.
For more details on financing and valuation for Reven, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Reven.
To read this article and more news on Reven, register or login.